| Enrolling By Invitation | Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease NCT05737602 | Massachusetts General Hospital | N/A |
| Enrolling By Invitation | SLC13A5 Deficiency Natural History Study - United States Only NCT06144957 | TESS Research Foundation | — |
| Enrolling By Invitation | SLC13A5 Deficiency Natural History Study - Remote Only NCT04681781 | TESS Research Foundation | — |
| Active Not Recruiting | Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes NCT04743466 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study NCT05212428 | Mayo Clinic | N/A |
| Completed | Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome) NCT03435627 | Novo Nordisk A/S | — |
| Unknown | Delineation of Novel Monogenic Disorders in the United Arab Emirates Population NCT03589079 | Imperial College London Diabetes Centre | — |
| Recruiting | Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart NCT06898307 | University Hospital of Ferrara | — |
| Unknown | Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis NCT03093220 | Peking University People's Hospital | — |
| Completed | Pediatric Patients With Metabolic or Other Genetic Disorders NCT02769949 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | — |
| Recruiting | Lipid Transport Disorder Italian Genetic Record (LIPIGEN) NCT06362473 | Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | — |
| Completed | Retrospective Study on Clinical Results of Preimplantation Genetic Screening at Different Embryo Stage NCT03065114 | Yeh | — |
| Active Not Recruiting | Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy NCT01851447 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | — |
| Completed | Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to No NCT01927861 | Novo Nordisk A/S | Phase 3 |
| Completed | A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin NCT01435629 | Novo Nordisk A/S | — |
| Recruiting | Inherited Reproductive Disorders NCT01500447 | National Institute of Environmental Health Sciences (NIEHS) | — |
| Completed | Brain-Derived Neurotrophic Factor in Obesity and Brain Function NCT01517048 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | — |
| Completed | Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers NCT01401244 | Novo Nordisk A/S | Phase 1 |
| Completed | Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated NCT01327924 | Novo Nordisk A/S | — |
| Completed | Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents NCT01245374 | Novo Nordisk A/S | Phase 4 |
| Terminated | Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants NCT01135537 | The Hospital for Sick Children | Phase 2 |
| Completed | Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrom NCT00705172 | Novo Nordisk A/S | — |
| Completed | Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658 NCT01529944 | Novo Nordisk A/S | Phase 3 |
| Terminated | Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant a NCT00358657 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Observational Prospective Study on Patients Treated With Norditropin® NCT00960128 | Novo Nordisk A/S | — |
| Completed | Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome NCT01604161 | Novo Nordisk A/S | — |
| Completed | Studies of Children With Metabolic and Other Genetic Disorders NCT00025870 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | — |
| Completed | Safety and Efficacy of Long-term Somatropin Treatment in Children NCT01543867 | Novo Nordisk A/S | — |
| Completed | Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency NCT01563926 | Novo Nordisk A/S | Phase 3 |
| Completed | Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome NCT01710696 | Novo Nordisk A/S | Phase 3 |
| Completed | Special Survey for Long Term Application NCT01516229 | Novo Nordisk A/S | — |
| Completed | Growth Response in Girls With Turner Syndrome NCT01734486 | Novo Nordisk A/S | Phase 4 |
| Completed | Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome NCT01529840 | Novo Nordisk A/S | Phase 3 |
| Completed | Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome NCT01518062 | Novo Nordisk A/S | Phase 4 |
| Completed | Use of Somatropin in Turner Syndrome NCT01518036 | Novo Nordisk A/S | Phase 3 |